PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515573
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515573
Automated External Defibrillators Market size was valued at USD 1,298.43 Million in 2023, expanding at a CAGR of 6.9% from 2024 to 2032.
An Automated External Defibrillator (AED) is a portable device designed to detect and treat sudden cardiac arrest (SCA) by delivering an electric shock to the heart. It works by analyzing the heart's rhythm through electrode pads placed on the chest of a person in cardiac arrest. If the device detects a life-threatening arrhythmia like ventricular fibrillation or ventricular tachycardia, it prompts the user to administer a shock to restore normal heart rhythm. AEDs are equipped with intuitive audio and visual instructions, making them accessible to bystanders and individuals with minimal medical training. They are widely used in public spaces, workplaces, schools, and healthcare settings to provide immediate intervention during cardiac emergencies, significantly improving the chances of survival for SCA victims.
Automated External Defibrillators Market- Market Dynamics
The rising incidence of coronary artery disease (CAD) is fueling growth in the AED market.
The increasing prevalence of coronary artery disease (CAD) is a significant factor driving the growth of the Automated External Defibrillator (AED) market. According to the World Health Organization (WHO), CAD is the leading cause of death globally, accounting for over 17 million deaths annually. CAD encompasses conditions such as heart attacks and sudden cardiac arrest (SCA), which can strike individuals without prior symptoms.
Heart-related organizations and health agencies worldwide emphasize the importance of early intervention in cardiac emergencies to improve survival rates. AEDs play a critical role in this regard by delivering timely electrical shocks to restore normal heart rhythm during SCA, significantly increasing the chances of survival. As CAD continues to rise due to ageing populations, sedentary lifestyles, and increasing rates of obesity and diabetes, the demand for AEDs is expected to grow steadily to meet the needs of public spaces, workplaces, and communities aiming to enhance cardiac emergency preparedness.
Automated External Defibrillators Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.9% over the forecast period (2024-2032)
Based on Product Type segmentation, fully automated external defibrillators were predicted to show maximum market share in the year 2023
Based on Patient segmentation, Adult was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Automated External Defibrillators Market is segmented based on Product Type, Patient, End User, and Region.
The market is divided into two categories based on Product Type: Semi-automated external defibrillators and fully automated external defibrillators. Fully automated external defibrillators (FAEDs) have gained popularity primarily due to their simplicity and effectiveness in emergencies. These devices are designed to be accessible and straightforward, requiring minimal training for operation. FAEDs automate the entire defibrillation process, from analyzing the heart rhythm to delivering a shock, if necessary, without the user needing to press any buttons.
The market is divided into two categories based on Patient: Adult and Pediatric. In the AED market, devices tailored for adult patients generally dominate due to their broader application and higher demand across public spaces, workplaces, and healthcare settings. Adult-focused AEDs are designed to effectively manage cardiac emergencies in adults, offering features and capabilities that cater specifically to the needs of adult patients experiencing sudden cardiac arrest.
Automated External Defibrillators Market- Geographical Insights
North America leads the AED market thanks to widespread adoption fueled by strong awareness and supportive regulations. Public awareness campaigns and proactive laws have promoted AED placement in crucial public locations like schools, airports, and workplaces. For example, recent legislation in Illinois (US) mandates schools to have AEDs and requires staff to undergo training in CPR and AED use as part of a comprehensive cardiac response plan. These measures aim to enhance emergency preparedness and improve outcomes during cardiac incidents across the continent. The region benefits from a strong healthcare infrastructure that facilitates the integration of AEDs into emergency response protocols, ensuring rapid access and deployment during cardiac emergencies.
Technological advancements also play a crucial role in North America's AED market dominance, with companies continuously innovating to enhance device functionality. These innovations include features like automated voice instructions, real-time CPR feedback, and integration with emergency medical services (EMS) systems for seamless coordination.
In the AED market, Koninklijke Philips N.V., Stryker Corporation, ZOLL Medical Corporation, Medtronic Group, and Nihon Kohden Corporation compete vigorously. Philips is renowned for user-friendly innovations, while Stryker emphasizes seamless integration. ZOLL offers real-time CPR feedback, Medtronic focuses on comprehensive cardiovascular solutions, and Nihon Kohden specializes in reliable, hospital-integrated AEDs. Each company's distinct strengths contribute to a competitive landscape aimed at enhancing emergency cardiac care outcomes.
Mergers and acquisitions (M&A) are crucial in shaping the AED market landscape. For instance, Zoll Medical recently completed the acquisition of Cardiac Science. This move consolidates their market presence and expands their product portfolios, as both companies provide trusted AED solutions across various segments of the public safety market.
In December 2023, during an 11-month trial in the suburbs of Gothenburg, Swedish researchers utilized drones to deliver AEDs directly to patients. They demonstrated a success rate of 67%, consistently reaching the scene of a medical emergency faster than ambulances.
In February 2023, two Medtronic implantable defibrillators, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan, received CE Mark approval. These devices are designed to regulate abnormal heart rhythms.
GLOBAL AUTOMATED EXTERNAL DEFIBRILLATORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Amiitalia
BPL Medical Technologies Pvt Ltd.
CU Medical Germany GmbH
Meditech Group
Mindray Medical International Limited
Nihon Kohden Corporation
Koninklijke Philips N.V.
Schiller AG
Stryker Corporation
ZOLL Medical Corporation
Progetti Srl
Mediana Co., Ltd.